Singapore, Singapore

Tiang Hin Jerry Tan

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Tarsus Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tiang Hin Jerry Tan. Retrieved from https://idiyas.com/inventor/tiang-hin-jerry-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tiang Hin Jerry Tan: Innovator in Pharmaceutical Compositions

Introduction

Tiang Hin Jerry Tan is a notable inventor based in Singapore, recognized for his contributions to the field of pharmaceuticals. He has developed innovative solutions aimed at treating specific medical conditions, particularly those related to eyelid inflammation.

Latest Patents

Tiang Hin Jerry Tan holds a patent for "Pharmaceutical compositions for demodex related blepharitis and eyelid crusting." This patent focuses on the formulation of ectoparasiticidal and antibiotic compositions that are useful for treating eyelid inflammation, specifically targeting demodex-related blepharitis and eye crusting.

Career Highlights

Currently, Tiang Hin Jerry Tan is associated with Tarsus Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work is instrumental in advancing treatments that address common yet challenging eye conditions.

Collaborations

Tiang Hin Jerry Tan collaborates with Yong Ming Por, contributing to the innovative environment at Tarsus Pharmaceuticals, Inc. Their combined efforts aim to enhance the effectiveness of treatments in the pharmaceutical industry.

Conclusion

Tiang Hin Jerry Tan's work exemplifies the impact of innovation in pharmaceuticals, particularly in addressing eyelid inflammation. His contributions are significant in improving patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…